Skip to content

A Clinical Study on the Benefits of Suvarnaprashan for Brain Development in Children

OPEN LABELLED SINGLE ARM CLINICAL TRIAL TO EVALUATE THE EFFECT OF SUVARNAPRASHAN ON MEDHA (COGNITIVE ABILITY) IN CHILDREN - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105335
Enrollment
48
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Shubham Vishnu Kakde
Lead Sponsor
CSMSS Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Chatrapati Sambhajinagar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Children of age group between 6yrs to 7 yrs Healthy children without an administration of any type of brain tonic No any special dietary supplements given to the children

Exclusion criteria

Exclusion criteria: Any children suffering from systemic disease, pneumonia, nephrotic syndrome and tuberculosis Any children taking brain tonic Congenital anomalies and hereditary diseases Sick children with infectious diseases and metabolic disorder Children with Anemia, HIV,HbsAg positive

Design outcomes

Primary

MeasureTime frame
Improvement in Medha (cognitive ability) in children, assessed using a standardized cognitive assessment scale.Timepoint: Every 4 weeks for 3 months

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr SHUBHAM VISHNU KAKDE

CSMSS AYURVED MAHAVIDYALAYA AND RUGNALAYA

anandjatal@gmail.com8275297743

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026